# Efficacy and Safety Study of IBI-10090 in Patients Undergoing Cataract Surgery

> **NCT01048593** · PHASE2 · TERMINATED · sponsor: **ICON Bioscience Inc** · enrollment: 6 (actual)

## Conditions studied

- Inflammatory Reaction Due to Ocular Lens Prosthesis

## Interventions

- **DRUG:** IBI-10090

## Key facts

- **NCT ID:** NCT01048593
- **Lead sponsor:** ICON Bioscience Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-01
- **Primary completion:** 2010-05
- **Final completion:** 2010-06
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Study was terminated in order to examine study data.
- **Last updated:** 2018-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01048593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01048593, "Efficacy and Safety Study of IBI-10090 in Patients Undergoing Cataract Surgery". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01048593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*